{"id":"34608060-7008-4c07-8e61-ba603936739e","kind":"institutions","code":"UB-I2077","name":"Takeda Pharmaceutical Co","nameBasis":"original-brand","summary":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","description":"Takeda Pharmaceutical, a large global pharmaceutical company making strategic life sciences investments through divisions including Takeda Ventures.","country":null,"category":null,"originalName":"Takeda Pharmaceutical Co","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.617Z","englishUpdatedAt":"2026-10-15T21:44:15.515Z","reviewedAt":"2026-10-15T21:44:15.515Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dd32345516d11666ed6d26c7709c5384c09df6df2a3abb241dd8ddbe317f77e8","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"武田药品工业，全球大型制药企业，通过Takeda Ventures等部门开展生命科学战略投资。","sources":[],"related":[{"id":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","kind":"news","code":"46b90fd5-9421-4d15-a20e-022fe7b89fc4","name":"Beacon Biosignals raises USD 86 million in Series B financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Beacon Biosignals完成8600万美元B轮融资","eventDate":"2025-11-14T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-10T18:51:48.824Z","englishUpdatedAt":"2026-10-15T17:19:59.451Z","reviewedAt":"2026-10-15T17:19:59.451Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1c9a8d7af2a0fd0178f098d60b67fb65728cdcb93f7a0735655a35de7b306f7a","companyId":"e3e6741f-8457-4043-8a49-2ea9f765c695","foundedYear":null,"logoUrl":null,"path":"/news/46b90fd5-9421-4d15-a20e-022fe7b89fc4"},{"id":"e81710a2-d2e8-453f-a45c-765216be5d62","kind":"news","code":"e81710a2-d2e8-453f-a45c-765216be5d62","name":"Iambic Therapeutics Acquired","nameBasis":"translated-title","summary":"On 2026/2/9, Xiniu Data reported that Iambic Therapeutics was acquired for USD 1.7 billion. The investor was Takeda Pharmaceutical Co.","description":"","country":null,"category":null,"originalName":"Iambic Therapeutics被收购","eventDate":"2026-02-09T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T12:42:31.117Z","englishUpdatedAt":"2026-10-15T22:01:50.908Z","reviewedAt":"2026-10-15T22:01:50.908Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"05bb6fe6b31fc38426bb468adf6ec3165a1c0114cbbdebe99f69fe694d50872f","companyId":"217c9186-2e9b-4e07-b192-25de64a27b49","foundedYear":null,"logoUrl":null,"path":"/news/e81710a2-d2e8-453f-a45c-765216be5d62"}],"path":"/institutions/takeda-pharmaceutical-co","structured":{"city":null,"country":"Japan","location":null,"role":null,"category":null,"company":null},"definition":"Takeda Pharmaceutical Co is a corporate venture capital investor based in Japan with 2 recorded investments in 2 companies.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/takeda-pharmaceutical-co"}